纵横研报
Ticker Detail

603351.SHG

¥26.32+4.94% 威尔药业 Drug Manufacturers - Specialty & Generic
00Reports China 医疗健康
Nanjing Well Pharmaceutical Co Ltd
医疗健康 · 专科与仿制药

Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical excipients and synthetic lubricating base oils to the pharmaceutical companies in China. It is involved in the bio-based material manufacturing, sales, and technology development; technical development and consulting; bio-based material technology research and development; biochemical product technology research and development; food and food additive production and sales; and research and development of new material technologies, as well as provides technical services; and manufactures and sells electronic materials. The company also exports its products to Europe, the United States, Southeast Asia, and internationally. The company was formerly known as Nanjing Well Pharmaceutical Co.,Ltd. and changed its name to Nanjing Well Pharmaceutical Group Co.,Ltd. in April 2020. Nanjing Well Pharmaceutical Group Co.,Ltd. was founded in 2000 and is based in Nanjing, China.

MARKET 市值 3.49B CNY PE 23.0x 52W ¥23.24 – ¥33.3 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY 1.9% ROE 8.4% 营业利润率 14.0% 净利润率 11.3%
ANALYST 股息率 2.37%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制